Recknor 's compensation at a large pharma as a director would pretty well parallel what he was being compensated as a VP with Cytodyn. There is no way they could bring him in as a VP with his experience level and they couldn't offer him that much of a better package. PIs come on board at the director level.
News 
Market Data 
Discover 
